Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-025279

Director acquired 5,120 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ray Amrit · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-19 Grant or award : show line 1 in the form +5,120 5,120 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-19 Grant or award : show line 2 in the form Stock Option (Right to Buy) +9,525 9,525 D
Loading xslF345X03/doc4.xml…